Envoy Medical Inc. has been awarded three patents—two from U.S. authorities and one from European officials.

Envision Medical Inc.已获得三项专利，其中两项来自美国当局，一项来自欧洲官员。

The patents are as follows:

专利如下：

U.S. Patent No. 11,839,765: 'Cochlear Implant System with Integrated Signal Analysis Functionality.'

U、 美国专利号11839765：“具有集成信号分析功能的人工耳蜗系统。”

US Patent No. 11,865,339: 'Cochlear Implant System with Electrode Impedance Diagnostics.'

美国专利号11865339：“具有电极阻抗诊断的人工耳蜗系统。”

European Patent No. 3927420: 'Implantable Cochlear System with Integrated Components and Lead Characterization.'

欧洲专利号3927420：“具有集成组件和铅表征的植入式耳蜗系统。”

“Investors, patients, and industry professionals may notice that Envoy Medical continues to grow its intellectual property portfolio as we provide patients with innovative hearing solutions,” Envoy Medical CEO Brent Lucas said. “We believe our system’s design will allow us an opportunity to separate ourselves from others and provide patients with a new hearing option.” .

“投资者、患者和行业专业人士可能会注意到，随着我们为患者提供创新的听力解决方案，Envision Medical继续扩大其知识产权组合，”Envision Medical首席执行官布伦特·卢卡斯（Brent Lucas）说。“我们相信，我们的系统设计将使我们有机会将自己与他人分开，并为患者提供新的听力选择。”。。

Headquartered in White Bear Lake, Minn., Envoy Medical develops hearing-related technologies. Its fully implanted Acclaim Cochlear Implant features a sensor designed to leverage the ear's natural anatomy rather than a microphone to capture sound. Intended to address severe to profound sensorineural hearing loss that is not adequately addressed by hearing aids, the Acclaim Cochlear Implant received U.S.

特使医疗公司总部位于明尼苏达州白熊湖，开发听力相关技术。其完全植入的广受欢迎的人工耳蜗具有一个传感器，该传感器旨在利用耳朵的自然解剖结构而不是麦克风来捕捉声音。该备受赞誉的人工耳蜗旨在解决助听器无法充分解决的严重至严重的感音神经性听力损失。

Food and Drug Administration Breakthrough Device Designation in 2019. 

2019年食品和药物管理局突破性设备指定。

The fully implanted Acclaim Cochlear Implant is an investigational device.

完全植入的鼓掌人工耳蜗是一种研究装置。